Robert M. Greenberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert M. Greenberg has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Ravi S. Kasinathan
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia, PA 19104, USA
6 shared publicationsSwarna Bais
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia, PA, 19104, USA
4 shared publicationsShanta M. Messerli
Marine Biological Laboratory Woods Hole Massachusetts USA
2 shared publications- Swarna Bais
Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA
2 shared publications - Vicenta Salvador-Recatalà
Ronin Institute for Independent Scholarship, Montclair, NJ, United States
2 shared publications William M. Morgan
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
2 shared publications
Latest Publications
- Open Access
- 1 August 2020
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 13, 1-7
Schistosome TRP channels: An appraisal
- 1 August 2020
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 13, 1-7
Open AccessSchistosome TRP channels: An appraisal
- Open Access
- 1 December 2018
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 8 (3) , 511-517
TRP channels as potential targets for antischistosomals
- 1 December 2018
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 8 (3) , 511-517
Open AccessTRP channels as potential targets for antischistosomals
- Open Access
- 10 May 2018
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 12 (5) , e0006495
Atypical pharmacology of schistosome TRPA1-like ion channels
Parasitic flatworms of the genus Schistosoma cause schistosomiasis, a neglected tropical disease estimated to affect over 200 million people worldwide. Praziquantel is the only antischistosomal currently available for treatment, and there is an urgent need for new therapeutics. Ion channels play key roles in physiology and are targets for many anthelmintics, yet only a few representatives have been characterized in any detail in schistosomes and other parasitic helminths. The transient receptor potential (TRP) channel superfamily comprises a diverse family of non-selective cation channels that play key roles in sensory transduction and a wide range of other functions. TRP channels fall into several subfamilies. Members of both the TRPA and TRPV subfamilies transduce nociceptive and inflammatory signals in mammals, and often also respond to chemical and thermal signals. We previously showed that although schistosomes contain no genes predicted to encode TRPV channels, TRPV1-selective activators such as capsaicin and resiniferatoxin elicit dramatic hyperactivity in adult worms and schistosomula. Surprisingly, this response requires expression of a S. mansoni TRPA1-like orthologue (SmTRPA). Here, we show that capsaicin induces a rise in intracellular Ca2+ in mammalian cells expressing either SmTRPA or a S. haematobium TRPA1 orthologue (ShTRPA). We also test SmTRPA and ShTRPA responses to various TRPV1 and TRPA1 modulators. Interestingly, in contrast to SmTRPA, ShTRPA is not activated by the TRPA1 activator AITC (allyl isothiocyanate), nor do S. haematobium adult worms respond to this compound, a potentially intriguing species difference. Notably, 4-hydroxynonenal (4-HNE), a host-derived, inflammatory product that directly activates mammalian TRPA1, also activates both SmTRPA and ShTRPA. Our results point to parasite TRPA1-like channels which exhibit atypical, mixed TRPA1/TRPV1-like pharmacology, and which may also function to transduce endogenous host signals. Schistosomes are parasitic flatworms that infect hundreds of millions of people worldwide. They cause schistosomiasis, a disease with major consequences for human health and economic development. There is only a single drug available for treatment and control of this highly prevalent disease, and there is an urgent need for development of new treatments. TRP ion channels play key roles in sensory (and other) functions. One type of TRP channel, TRPV1, is activated by capsaicin, the active ingredient in hot peppers. However, schistosomes do not have any TRPV-like channels. Nonetheless, we previously showed that capsaicin and similar compounds induce dramatic hyperactivity in schistosomes, and that this response is abolished by suppressing expression of SmTRPA, a schistosome TRPA1-like channel. Mammalian TRPA1 channels are not sensitive to capsaicin. Here, we show that the SmTRPA channel itself responds to capsaicin, resulting in an influx of Ca2+ into cells. ShTRPA, a TRPA1-like channel from another schistosome, S. haematobium, is also sensitive to capsaicin. Thus, the pharmacology of schistosome TRPA1 channels apparently differs from that of host mammalian channels, a characteristic that could indicate mixed TRPA/TRPV functionality and might be exploitable for development of new antischistosomal drugs. Furthermore, we show that schistosome TRPA1-like channels are activated by host-derived compounds, perhaps indicating a mechanism by which the parasite can respond to host signals.
- 10 May 2018
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 12 (5) , e0006495
Open AccessAtypical pharmacology of schistosome TRPA1-like ion channels
Parasitic flatworms of the genus Schistosoma cause schistosomiasis, a neglected tropical disease estimated to affect over 200 million people worldwide. Praziquantel is the only antischistosomal currently available for treatment, and there is an urgent need for new therapeutics. Ion channels play key roles in physiology and are targets for many anthelmintics, yet only a few representatives have been characterized in any detail in schistosomes and other parasitic helminths. The transient receptor potential (TRP) channel superfamily comprises a diverse family of non-selective cation channels that play key roles in sensory transduction and a wide range of other functions. TRP channels fall into several subfamilies. Members of both the TRPA and TRPV subfamilies transduce nociceptive and inflammatory signals in mammals, and often also respond to chemical and thermal signals. We previously showed that although schistosomes contain no genes predicted to encode TRPV channels, TRPV1-selective activators such as capsaicin and resiniferatoxin elicit dramatic hyperactivity in adult worms and schistosomula. Surprisingly, this response requires expression of a S. mansoni TRPA1-like orthologue (SmTRPA). Here, we show that capsaicin induces a rise in intracellular Ca2+ in mammalian cells expressing either SmTRPA or a S. haematobium TRPA1 orthologue (ShTRPA). We also test SmTRPA and ShTRPA responses to various TRPV1 and TRPA1 modulators. Interestingly, in contrast to SmTRPA, ShTRPA is not activated by the TRPA1 activator AITC (allyl isothiocyanate), nor do S. haematobium adult worms respond to this compound, a potentially intriguing species difference. Notably, 4-hydroxynonenal (4-HNE), a host-derived, inflammatory product that directly activates mammalian TRPA1, also activates both SmTRPA and ShTRPA. Our results point to parasite TRPA1-like channels which exhibit atypical, mixed TRPA1/TRPV1-like pharmacology, and which may also function to transduce endogenous host signals. Schistosomes are parasitic flatworms that infect hundreds of millions of people worldwide. They cause schistosomiasis, a disease with major consequences for human health and economic development. There is only a single drug available for treatment and control of this highly prevalent disease, and there is an urgent need for development of new treatments. TRP ion channels play key roles in sensory (and other) functions. One type of TRP channel, TRPV1, is activated by capsaicin, the active ingredient in hot peppers. However, schistosomes do not have any TRPV-like channels. Nonetheless, we previously showed that capsaicin and similar compounds induce dramatic hyperactivity in schistosomes, and that this response is abolished by suppressing expression of SmTRPA, a schistosome TRPA1-like channel. Mammalian TRPA1 channels are not sensitive to capsaicin. Here, we show that the SmTRPA channel itself responds to capsaicin, resulting in an influx of Ca2+ into cells. ShTRPA, a TRPA1-like channel from another schistosome, S. haematobium, is also sensitive to capsaicin. Thus, the pharmacology of schistosome TRPA1 channels apparently differs from that of host mammalian channels, a characteristic that could indicate mixed TRPA/TRPV functionality and might be exploitable for development of new antischistosomal drugs. Furthermore, we show that schistosome TRPA1-like channels are activated by host-derived compounds, perhaps indicating a mechanism by which the parasite can respond to host signals.
- 21 June 2017
- Published by Springer Nature
- p. 705-734
Chemotherapy and Drug Resistance in Schistosomiasis and Other Trematode and Cestode Infections
- 21 June 2017
- Published by Springer Nature
- p. 705-734
Chemotherapy and Drug Resistance in Schistosomiasis and Other Trematode and Cestode Infections
- Open Access
- 1 December 2016
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 6 (3) , 335-342
TRP channels in schistosomes
- 1 December 2016
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 6 (3) , 335-342
Open AccessTRP channels in schistosomes
- Open Access
- 31 December 2015
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 9 (12) , e0004318
Molecular Detection of Schistosome Infections with a Disposable Microfluidic Cassette
Parasitic helminths such as schistosomes, as well as filarial and soil-transmitted nematodes, are estimated to infect at least a billion people worldwide, with devastating impacts on human health and economic development. Diagnosis and monitoring of infection dynamics and efficacy of treatment depend almost entirely on methods that are inaccurate, labor-intensive, and unreliable. These shortcomings are amplified and take on added significance in mass drug administration programs, where measures of effectiveness depend on accurate monitoring of treatment success (or failure), changes in disease transmission rates, and emergence of possible drug resistance. Here, we adapt isothermal molecular assays such as loop-mediated isothermal amplification (LAMP) to a simple, hand-held, custom-made field-ready microfluidic device that allows sensitive and specific detection of schistosome cell-free nucleic acids in serum and plasma (separated with a point-of-care plasma separator) from Schistosoma mansoni-infected mice. Cell-free S. mansoni DNA was detected with our device without prior extraction from blood. Our chip exhibits high sensitivity (~2x10−17 g/μL), with a positive signal for S. mansoni DNA detectable as early as one week post infection, several weeks before parasite egg production commences. These results indicate that incorporation of isothermal amplification strategies with our chips could represent a strategy for rapid, simple, low-cost diagnosis of both pre-patent and chronic schistosome infections as well as potential monitoring of treatment efficacy. Schistosomes infect hundreds of millions of people worldwide, with devastating effects on human health and economic development. One of the major challenges in treatment and control of these diseases is the accurate diagnosis of infection and monitoring of transmission dynamics. Current parasitological and serological diagnostic tests often lack sensitivity, accuracy, and reliability; more sensitive and specific molecular methods require infrastructure typically unavailable in resource-limited settings. Here, we have detected cell-free parasitic helminth DNA in serum and plasma from schistosome-infected mice using LAMP, an isothermal amplification technique, in a simple, hand-held, custom-made, field-ready microfluidic device we have developed. Schistosome DNA is detectable as early as one week following infection, long before the worms have matured and begun producing eggs. The device is small, entirely self-contained and disposable, and is readily adaptable to rapid and simple point-of-contact (POC) detection of infection. The entire process from sample collection to diagnosis can be carried out on-site, without any laboratory equipment.
- 31 December 2015
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 9 (12) , e0004318
Open AccessMolecular Detection of Schistosome Infections with a Disposable Microfluidic Cassette
Parasitic helminths such as schistosomes, as well as filarial and soil-transmitted nematodes, are estimated to infect at least a billion people worldwide, with devastating impacts on human health and economic development. Diagnosis and monitoring of infection dynamics and efficacy of treatment depend almost entirely on methods that are inaccurate, labor-intensive, and unreliable. These shortcomings are amplified and take on added significance in mass drug administration programs, where measures of effectiveness depend on accurate monitoring of treatment success (or failure), changes in disease transmission rates, and emergence of possible drug resistance. Here, we adapt isothermal molecular assays such as loop-mediated isothermal amplification (LAMP) to a simple, hand-held, custom-made field-ready microfluidic device that allows sensitive and specific detection of schistosome cell-free nucleic acids in serum and plasma (separated with a point-of-care plasma separator) from Schistosoma mansoni-infected mice. Cell-free S. mansoni DNA was detected with our device without prior extraction from blood. Our chip exhibits high sensitivity (~2x10−17 g/μL), with a positive signal for S. mansoni DNA detectable as early as one week post infection, several weeks before parasite egg production commences. These results indicate that incorporation of isothermal amplification strategies with our chips could represent a strategy for rapid, simple, low-cost diagnosis of both pre-patent and chronic schistosome infections as well as potential monitoring of treatment efficacy. Schistosomes infect hundreds of millions of people worldwide, with devastating effects on human health and economic development. One of the major challenges in treatment and control of these diseases is the accurate diagnosis of infection and monitoring of transmission dynamics. Current parasitological and serological diagnostic tests often lack sensitivity, accuracy, and reliability; more sensitive and specific molecular methods require infrastructure typically unavailable in resource-limited settings. Here, we have detected cell-free parasitic helminth DNA in serum and plasma from schistosome-infected mice using LAMP, an isothermal amplification technique, in a simple, hand-held, custom-made, field-ready microfluidic device we have developed. Schistosome DNA is detectable as early as one week following infection, long before the worms have matured and begun producing eggs. The device is small, entirely self-contained and disposable, and is readily adaptable to rapid and simple point-of-contact (POC) detection of infection. The entire process from sample collection to diagnosis can be carried out on-site, without any laboratory equipment.
- Open Access
- 11 December 2015
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 9 (12) , e0004295
Evidence for Novel Pharmacological Sensitivities of Transient Receptor Potential (TRP) Channels in Schistosoma mansoni
Schistosomiasis, caused by parasitic flatworms of the genus Schistosoma, is a neglected tropical disease affecting hundreds of millions globally. Praziquantel (PZQ), the only drug currently available for treatment and control, is largely ineffective against juvenile worms, and reports of PZQ resistance lend added urgency to the need for development of new therapeutics. Ion channels, which underlie electrical excitability in cells, are validated targets for many current anthelmintics. Transient receptor potential (TRP) channels are a large family of non-selective cation channels. TRP channels play key roles in sensory transduction and other critical functions, yet the properties of these channels have remained essentially unexplored in parasitic helminths. TRP channels fall into several (7–8) subfamilies, including TRPA and TRPV. Though schistosomes contain genes predicted to encode representatives of most of the TRP channel subfamilies, they do not appear to have genes for any TRPV channels. Nonetheless, we find that the TRPV1-selective activators capsaicin and resiniferatoxin (RTX) induce dramatic hyperactivity in adult worms; capsaicin also increases motility in schistosomula. SB 366719, a highly-selective TRPV1 antagonist, blocks the capsaicin-induced hyperactivity in adults. Mammalian TRPA1 is not activated by capsaicin, yet knockdown of the single predicted TRPA1-like gene (SmTRPA) in S. mansoni effectively abolishes capsaicin-induced responses in adult worms, suggesting that SmTRPA is required for capsaicin sensitivity in these parasites. Based on these results, we hypothesize that some schistosome TRP channels have novel pharmacological sensitivities that can be targeted to disrupt normal parasite neuromuscular function. These results also have implications for understanding the phylogeny of metazoan TRP channels and may help identify novel targets for new or repurposed therapeutics. Schistosomes, infect hundreds of millions of people worldwide, causing schistosomiasis, a disease with devastating effects on human health and economic development. Despite the prevalence of this disease, there is only a single drug, praziquantel, available for treatment and control. Praziquantel is effective, but has limitations, and reports of drug resistance lend increased urgency to development of new treatments. Ion channels are critical components of animal neuromuscular systems, and have proven to be excellent targets for drugs against parasitic worm infections. TRP ion channels, which play important roles in sensory functions, have received little attention in parasitic helminths. One class of TRP channels, TRPV, is activated by capsaicin. However, schistosomes do not appear to contain any TRPV channels. Nonetheless, we find that they are highly sensitive to capsaicin and similar compounds, responding by dramatically increasing their motor activity. Unexpectedly, suppressing expression of a different schistosome TRP channel, TRPA1, which in mammals is not sensitive to capsaicin, almost completely eliminates this response. Thus, it appears that the pharmacology of schistosome TRP channels differs from that of host mammalian channels, a characteristic that might be exploitable for development of new antischistosomal drugs.
- 11 December 2015
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 9 (12) , e0004295
Open AccessEvidence for Novel Pharmacological Sensitivities of Transient Receptor Potential (TRP) Channels in Schistosoma mansoni
Schistosomiasis, caused by parasitic flatworms of the genus Schistosoma, is a neglected tropical disease affecting hundreds of millions globally. Praziquantel (PZQ), the only drug currently available for treatment and control, is largely ineffective against juvenile worms, and reports of PZQ resistance lend added urgency to the need for development of new therapeutics. Ion channels, which underlie electrical excitability in cells, are validated targets for many current anthelmintics. Transient receptor potential (TRP) channels are a large family of non-selective cation channels. TRP channels play key roles in sensory transduction and other critical functions, yet the properties of these channels have remained essentially unexplored in parasitic helminths. TRP channels fall into several (7–8) subfamilies, including TRPA and TRPV. Though schistosomes contain genes predicted to encode representatives of most of the TRP channel subfamilies, they do not appear to have genes for any TRPV channels. Nonetheless, we find that the TRPV1-selective activators capsaicin and resiniferatoxin (RTX) induce dramatic hyperactivity in adult worms; capsaicin also increases motility in schistosomula. SB 366719, a highly-selective TRPV1 antagonist, blocks the capsaicin-induced hyperactivity in adults. Mammalian TRPA1 is not activated by capsaicin, yet knockdown of the single predicted TRPA1-like gene (SmTRPA) in S. mansoni effectively abolishes capsaicin-induced responses in adult worms, suggesting that SmTRPA is required for capsaicin sensitivity in these parasites. Based on these results, we hypothesize that some schistosome TRP channels have novel pharmacological sensitivities that can be targeted to disrupt normal parasite neuromuscular function. These results also have implications for understanding the phylogeny of metazoan TRP channels and may help identify novel targets for new or repurposed therapeutics. Schistosomes, infect hundreds of millions of people worldwide, causing schistosomiasis, a disease with devastating effects on human health and economic development. Despite the prevalence of this disease, there is only a single drug, praziquantel, available for treatment and control. Praziquantel is effective, but has limitations, and reports of drug resistance lend increased urgency to development of new treatments. Ion channels are critical components of animal neuromuscular systems, and have proven to be excellent targets for drugs against parasitic worm infections. TRP ion channels, which play important roles in sensory functions, have received little attention in parasitic helminths. One class of TRP channels, TRPV, is activated by capsaicin. However, schistosomes do not appear to contain any TRPV channels. Nonetheless, we find that they are highly sensitive to capsaicin and similar compounds, responding by dramatically increasing their motor activity. Unexpectedly, suppressing expression of a different schistosome TRP channel, TRPA1, which in mammals is not sensitive to capsaicin, almost completely eliminates this response. Thus, it appears that the pharmacology of schistosome TRP channels differs from that of host mammalian channels, a characteristic that might be exploitable for development of new antischistosomal drugs.
- Open Access
- 1 December 2014
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 4 (3) , 301-309
Schistosome ABC multidrug transporters: From pharmacology to physiology
- 1 December 2014
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 4 (3) , 301-309
Open AccessSchistosome ABC multidrug transporters: From pharmacology to physiology
- Open Access
- 16 October 2014
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 8 (10) , e3265
Inhibition or Knockdown of ABC Transporters Enhances Susceptibility of Adult and Juvenile Schistosomes to Praziquantel
Parasitic flatworms of the genus Schistosoma cause schistosomiasis, a neglected tropical disease that affects hundreds of millions. Treatment of schistosomiasis depends almost entirely on the drug praziquantel (PZQ). Though essential to treating and controlling schistosomiasis, a major limitation of PZQ is that it is not active against immature mammalian-stage schistosomes. Furthermore, there are reports of field isolates with heritable reductions in PZQ susceptibility, and researchers have selected for PZQ-resistant schistosomes in the laboratory. P-glycoprotein (Pgp; ABCB1) and other ATP binding cassette (ABC) transporters remove a wide variety of toxins and xenobiotics from cells, and have been implicated in multidrug resistance (MDR). Changes in ABC transporter structure or expression levels are also associated with reduced drug susceptibility in parasitic helminths, including schistosomes. Here, we show that the activity of PZQ against schistosome adults and juveniles ex vivo is potentiated by co-administration of either the highly potent Pgp inhibitor tariquidar or combinations of inhibitors targeting multiple ABC multidrug transporters. Adult worms exposed to sublethal PZQ concentrations remain active, but co-administration of ABC transporter inhibitors results in complete loss of motility and disruption of the tegument. Notably, juvenile schistosomes (3–4 weeks post infection), normally refractory to 2 µM PZQ, become paralyzed when transporter inhibitors are added in combination with the PZQ. Experiments using the fluorescent PZQ derivative (R)-PZQ-BODIPY are consistent with the transporter inhibitors increasing effective intraworm concentrations of PZQ. Adult worms in which expression of ABC transporters has been suppressed by RNA interference show increased responsiveness to PZQ and increased retention of (R)-PZQ-BODIPY consistent with an important role for these proteins in setting levels of PZQ susceptibility. These results indicate that parasite ABC multidrug transporters might serve as important targets for enhancing the action of PZQ. They also suggest a potentially novel and readily-available strategy for overcoming reduced PZQ susceptibility of schistosomes. Schistosomes are parasitic flatworms that cause schistosomiasis, a tropical disease affecting hundreds of millions worldwide. Praziquantel (PZQ) is the current drug of choice against schistosomiasis, and, indeed, is the only approved antischistosomal treatment available in most parts of the world. Though effective overall, PZQ has limitations, including its lack of activity against immature schistosomes. Furthermore, reported cure rates in the field are often below optimal levels, and there is increasing evidence that schistosomes can become resistant to the drug. ABC transporters such as P-glycoprotein are efflux transporters that mediate detoxification of cells via removal of toxins and xenobiotics, including drugs. They underlie multidrug resistance in mammalian cells, and are also associated with drug resistance in parasitic worms, including schistosomes. Here, we show that compounds that inhibit these efflux transporters potentiate the activity of PZQ against schistosomes, including normally PZQ-insensitive juvenile worms. Similarly, suppressing expression of these transporters also increases adult worm responsiveness to PZQ. Our experiments may provide insights into the role of these drug transporters in PZQ action, and could also translate into new therapeutic strategies for augmenting treatment of schistosome infections and overcoming drug resistance.
- 16 October 2014
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 8 (10) , e3265
Open AccessInhibition or Knockdown of ABC Transporters Enhances Susceptibility of Adult and Juvenile Schistosomes to Praziquantel
Parasitic flatworms of the genus Schistosoma cause schistosomiasis, a neglected tropical disease that affects hundreds of millions. Treatment of schistosomiasis depends almost entirely on the drug praziquantel (PZQ). Though essential to treating and controlling schistosomiasis, a major limitation of PZQ is that it is not active against immature mammalian-stage schistosomes. Furthermore, there are reports of field isolates with heritable reductions in PZQ susceptibility, and researchers have selected for PZQ-resistant schistosomes in the laboratory. P-glycoprotein (Pgp; ABCB1) and other ATP binding cassette (ABC) transporters remove a wide variety of toxins and xenobiotics from cells, and have been implicated in multidrug resistance (MDR). Changes in ABC transporter structure or expression levels are also associated with reduced drug susceptibility in parasitic helminths, including schistosomes. Here, we show that the activity of PZQ against schistosome adults and juveniles ex vivo is potentiated by co-administration of either the highly potent Pgp inhibitor tariquidar or combinations of inhibitors targeting multiple ABC multidrug transporters. Adult worms exposed to sublethal PZQ concentrations remain active, but co-administration of ABC transporter inhibitors results in complete loss of motility and disruption of the tegument. Notably, juvenile schistosomes (3–4 weeks post infection), normally refractory to 2 µM PZQ, become paralyzed when transporter inhibitors are added in combination with the PZQ. Experiments using the fluorescent PZQ derivative (R)-PZQ-BODIPY are consistent with the transporter inhibitors increasing effective intraworm concentrations of PZQ. Adult worms in which expression of ABC transporters has been suppressed by RNA interference show increased responsiveness to PZQ and increased retention of (R)-PZQ-BODIPY consistent with an important role for these proteins in setting levels of PZQ susceptibility. These results indicate that parasite ABC multidrug transporters might serve as important targets for enhancing the action of PZQ. They also suggest a potentially novel and readily-available strategy for overcoming reduced PZQ susceptibility of schistosomes. Schistosomes are parasitic flatworms that cause schistosomiasis, a tropical disease affecting hundreds of millions worldwide. Praziquantel (PZQ) is the current drug of choice against schistosomiasis, and, indeed, is the only approved antischistosomal treatment available in most parts of the world. Though effective overall, PZQ has limitations, including its lack of activity against immature schistosomes. Furthermore, reported cure rates in the field are often below optimal levels, and there is increasing evidence that schistosomes can become resistant to the drug. ABC transporters such as P-glycoprotein are efflux transporters that mediate detoxification of cells via removal of toxins and xenobiotics, including drugs. They underlie multidrug resistance in mammalian cells, and are also associated with drug resistance in parasitic worms, including schistosomes. Here, we show that compounds that inhibit these efflux transporters potentiate the activity of PZQ against schistosomes, including normally PZQ-insensitive juvenile worms. Similarly, suppressing expression of these transporters also increases adult worm responsiveness to PZQ. Our experiments may provide insights into the role of these drug transporters in PZQ action, and could also translate into new therapeutic strategies for augmenting treatment of schistosome infections and overcoming drug resistance.
- 16 September 2014
- Published by Springer Nature in Current Clinical Microbiology Reports
- Vol. 1 (3-4) , 51-60
Ion Channels and Drug Transporters as Targets for Anthelmintics
Infections with parasitic helminthes, such as schistosomes and soil-transmitted nematodes, are hugely prevalent and are responsible for a major portion of the global health and economic burdens associated with neglected tropical diseases. In addition, many of these parasites infect livestock and plants used in agriculture, resulting in further impoverishment. Treatment and control of these pathogens relies on anthelmintic drugs, which are few in number, and against which drug resistance can rapidly develop. The neuromuscular system of the parasite, and in particular, the ion channels and associated receptors underlying excitation and signaling, have proven to be outstanding targets for anthelmintics. This review surveys the different ion channels found in helminths, focusing on their unique characteristics and pharmacological sensitivities. It also briefly reviews the literature on helminth multidrug efflux that may modulate parasite susceptibility to anthelmintics and may prove useful targets for new or repurposed agents that can enhance parasite drug susceptibility and perhaps overcome drug resistance.
- 16 September 2014
- Published by Springer Nature in Current Clinical Microbiology Reports
- Vol. 1 (3-4) , 51-60
Ion Channels and Drug Transporters as Targets for Anthelmintics
Infections with parasitic helminthes, such as schistosomes and soil-transmitted nematodes, are hugely prevalent and are responsible for a major portion of the global health and economic burdens associated with neglected tropical diseases. In addition, many of these parasites infect livestock and plants used in agriculture, resulting in further impoverishment. Treatment and control of these pathogens relies on anthelmintic drugs, which are few in number, and against which drug resistance can rapidly develop. The neuromuscular system of the parasite, and in particular, the ion channels and associated receptors underlying excitation and signaling, have proven to be outstanding targets for anthelmintics. This review surveys the different ion channels found in helminths, focusing on their unique characteristics and pharmacological sensitivities. It also briefly reviews the literature on helminth multidrug efflux that may modulate parasite susceptibility to anthelmintics and may prove useful targets for new or repurposed agents that can enhance parasite drug susceptibility and perhaps overcome drug resistance.